Technology

January 9, 2012 - GE Healthcare announced the Brivo NM615 has received clearance from the U.S. Food and Drug Administration (FDA).

Home January 09, 2012
Home
News

January 9, 2012 – A registry that includes every patient in Sweden having percutaneous coronary intervention (PCI) found use of newer generation drug-eluting stents (DES) is associated with lower rates of restenosis, stent thrombosis and mortality than older DES and bare-metal stents.

Home January 09, 2012
Home
News

January 6, 2012 – Bracco Diagnostics said it plans to close out the recall process for its CardioGen-82 cardiac perfusion radiotracer with a list of actions to bring the product back to market.

Home January 06, 2012
Home
News

January 6, 2012 - C. R. Bard recently announced it acquired drug-eluting balloon maker Lutonix Inc. for $225 million. Following successful approval of a U.S. Food and Drug Administration (FDA) pre-market approval (PMA), an additional $100 million will be paid.

Home January 06, 2012
Home
News

January 6, 2012 - Bracco Imaging SpA has acquired Swiss Medical Care (SMC), a Swiss company headquartered in Lausanne and engaged in research, production and marketing of automated systems for the administration of contrast agents for diagnostic imaging.

Home January 06, 2012
Home
News

January 6, 2012 – A study led by researchers from the University of North Carolina at Chapel Hill School of Medicine has identified a molecular pathway that leads to this abnormal blood clotting and have turned it off using a popular class of cholesterol-lowering drugs; statins.

Home January 06, 2012
Home
News

January 5, 2012 – Ambucor Health Solutions (AHS) has said it is expanding its cardiovascular implantable electronic devices (CIED) monitoring program for pacemaker and implantable cardioverter defibrillator (ICD) monitoring services.

Home January 05, 2012
Home
News

January 5, 2011 – Bayer HealthCare's oral anticoagulant tablet Xarelto (rivaroxaban) has been approved for use in the United Kingdom in two important blood-clotting disorders

Home January 05, 2012
Home
Technology

January 5, 2012 – During RSNA 2011, TeraRecon Inc. demonstrated a suite of innovative tools for its iNtuition solution to support new applications for volumetric acquisition modalities, such as computed tomography (CT), magnetic resonance (MR) and positron emission tomography (PET).

Home January 05, 2012
Home
News

January 4, 2012 - A study reported in the current issue of Pediatric and Developmental Pathology compares cardiac tissue from 12 patients with histiocytoid cardiomyopathy (HC) and 12 age-matched controls. Researchers found differences in gene expression that could indicate a predisposition for HC.

Home January 04, 2012
Home
News

January 4, 2012 – ECRI, an independent nonprofit that researches the best approaches to improving patient care, listed 10 health technology issues that hospital leaders should have on their watch lists for 2012. The list takes into account critical patient safety, as well as economic and regulatory pressures currently facing healthcare executives.

Home January 04, 2012
Home
News

January 3, 2012 — Independent research firm KLAS has named Hitachi’s Oasis High-field Open MRI (magnetic resonance imaging) as the Open category leader for the second consecutive year in its “Top 20 Best in KLAS Awards” report. KLAS presented this award to Hitachi Medical Systems America at an RSNA 2011 reception on Nov. 27, 2011.

Home January 03, 2012
Home
Technology

January 3, 2012— In 2011, Hitachi Medical Corp. acquired Aloka Company and formed Hitachi Aloka Medical. The new company exhibited its expanded line of ultrasound products in Hitachi’s booth at RSNA 2011.

Home January 03, 2012
Home
News

January 3, 2012 – Siemens Healthcare recently announced the winners of its 2011 International CT [computed tomography] Image Contest. More than 160 institutes and hospitals from 43 countries on all continents submitted more than 600 CT images –– all captured on Siemens CT scanners using the lowest possible radiation dose. Selected by an international jury of experts, the seven winners –– which were displayed at RSNA 2011 –– hail from China, England, France, Ireland, Macau, Singapore and the United States. In addition to exhibiting a high standard of quality, the images are impressive examples of how valuable diagnostic information can be obtained even at an extremely low dose.

Home January 03, 2012
Home
News

January 3, 2012 – Ikaria Inc. announced it commenced its global development program, the PRESERVATION I clinical trial, for its Bioabsorbable Cardiac Matrix (BCM). The CE mark registration trial has commenced in Australia, and will be followed in Europe. The trial also is expected to commence in other countries, including Israel.

Home January 03, 2012
Home
Subscribe Now